Recurrent Pregnancy Loss in Uttar Pradesh: Causes, Diagnosis & Evidence-Based Treatment

Recurrent Pregnancy Loss (RPL) is not simply a streak of bad luck. It is a distinct clinical condition with identifiable causes in the majority of cases. The European Society of Human Reproduction and Embryology (ESHRE) defines RPL as two or more failed clinical pregnancies, confirmed by ultrasound or histopathology. Some clinicians in India — including those advising the HomeIVF Medical Board — begin investigation after two losses, especially when the patient is over 35 or has had a previous live birth.

It is important to distinguish RPL from infertility. Many couples experiencing RPL conceive without difficulty — the problem lies in sustaining the pregnancy. This distinction matters enormously for treatment planning. A couple in Noida or Ghaziabad who conceives quickly but repeatedly miscarries needs a very different clinical pathway than a couple who struggles to conceive at all.

Understanding the definition helps couples advocate for themselves. If your gynaecologist has not yet offered a full RPL panel after two losses, you are within your rights — and medically supported — in requesting one. HomeIVF's care coordinators can help you initiate this process from anywhere in Uttar Pradesh.

The causes of RPL are multifactorial, and in roughly 25–30% of cases, no single identifiable cause is found even after thorough investigation — a category called "unexplained RPL." However, for the majority, structured testing uncovers actionable findings.

**Chromosomal & Genetic Factors:** Embryonic aneuploidy (abnormal chromosome number) is the single largest cause, responsible for 50–60% of first-trimester losses. Parental chromosomal structural abnormalities — such as balanced translocations — are found in 3–5% of RPL couples and significantly elevate miscarriage risk with each conception.

**Uterine Structural Abnormalities:** Conditions such as a septate uterus, submucous fibroids, intrauterine adhesions (Asherman's syndrome), or a bicornuate uterus can mechanically impair implantation or placentation. These are particularly relevant for women in semi-urban parts of Uttar Pradesh who may have had prior uterine procedures without follow-up imaging.

**Thrombophilias:** Antiphospholipid Syndrome (APS) — an autoimmune clotting disorder — is one of the few completely treatable causes of RPL. It accounts for roughly 10–15% of cases. Other inherited thrombophilias like Factor V Leiden mutation also contribute.

**Hormonal & Endocrine Disorders:** Poorly controlled thyroid disease (both hypothyroidism and hyperthyroidism), uncontrolled diabetes, hyperprolactinaemia, and polycystic ovarian syndrome (PCOS) all elevate miscarriage risk. PCOS is highly prevalent in Uttar Pradesh and is a frequently overlooked contributor.

**Immunological Factors:** Natural killer (NK) cell dysregulation and other immune factors are an area of active research. While not all immunological treatments are proven, testing for APS is firmly evidence-based.

**Male Factor Contribution:** Sperm DNA fragmentation — where the genetic material inside sperm is damaged — is increasingly recognised as a contributor to both embryo arrest and early miscarriage. This is often missed when only a basic semen analysis is performed.

RPL does not always announce itself dramatically. Some losses occur so early that a woman may think she simply had a late, heavy period — a biochemical pregnancy. Recognising the pattern is key to seeking timely help.

Warning signs that warrant a formal RPL evaluation include: two or more pregnancy losses at any gestation, one loss after 10 weeks (as later losses are more likely to have structural or thrombophilic causes), a history of fetal cardiac activity followed by demise (missed miscarriage), or any pregnancy loss accompanied by abnormal clotting or unusual bleeding patterns.

In Varanasi and other tier-2 cities in Uttar Pradesh, women sometimes normalise repeated losses, attributing them to fate or stress. While psychological stress is a real companion to RPL, it is rarely a primary cause. Emotional distress is a consequence of RPL — not its root. Couples should know that help is available and that most causes, once identified, are manageable.

If you have experienced even two losses — regardless of whether you have a living child — please do not wait for a third. The HomeIVF platform connects you with a specialist who can order and interpret a full RPL panel without requiring you to travel to a metro hospital.

A thorough RPL workup typically spans several domains and should be completed systematically rather than piecemeal. The HomeIVF Medical Board recommends the following evidence-based panel for couples in Uttar Pradesh presenting with recurrent losses.

**Genetic Testing:** Karyotyping of both partners to identify balanced translocations or chromosomal inversions. If possible, products of conception (POC) from the most recent miscarriage should be sent for chromosomal microarray analysis — this yields far more information than standard karyotyping of the miscarried tissue.

**Uterine Assessment:** A 3D transvaginal ultrasound or saline infusion sonohysterogram (SIS) is the first-line tool. Where findings are ambiguous, hysteroscopy provides direct visualisation and the ability to treat simultaneously. MRI of the pelvis may be needed for complex Müllerian anomalies.

**Thrombophilia Screen:** Anticardiolipin antibodies, lupus anticoagulant, anti-beta-2 glycoprotein-I antibodies (tested on two occasions 12 weeks apart to confirm APS), and inherited thrombophilia markers including Factor V Leiden and prothrombin gene mutation.

**Hormonal Panel:** TSH (thyroid-stimulating hormone), fasting insulin, fasting glucose, HbA1c, prolactin, AMH, and a Day-2/3 FSH and LH profile. Women with PCOS — prevalent across Lucknow, Kanpur, and surrounding districts — should also have a fasting lipid profile.

**Sperm DNA Fragmentation Index (DFI):** A DFI above 25% is associated with increased miscarriage risk. This simple test is underutilised in Uttar Pradesh but can change treatment strategy significantly.

HomeIVF coordinates sample collection at home or at nearby partner labs, ensuring that couples in Agra or Ghaziabad do not need to repeatedly visit multiple facilities.

Treatment for RPL is cause-specific, and this is precisely why thorough diagnosis matters so much before jumping to intervention.

**For APS:** Low-molecular-weight heparin (LMWH) combined with low-dose aspirin is the standard of care and dramatically improves live-birth rates — from approximately 10–15% untreated to 70–75% with treatment in confirmed APS-RPL couples. This protocol is well within the scope of HomeIVF-coordinated care.

**For Uterine Anomalies:** Hysteroscopic septum resection for a uterine septum is a day-procedure with strong evidence for improving outcomes. Adhesiolysis for Asherman's syndrome and myomectomy for submucous fibroids are performed by surgical specialists, with HomeIVF providing pre- and post-operative coordination.

**For Thyroid and Hormonal Issues:** Optimising TSH to below 2.5 mIU/L before conception, and managing PCOS with metformin or inositol protocols, are low-cost, high-impact interventions that are often overlooked in routine care across Uttar Pradesh.

**For High Sperm DNA Fragmentation:** Antioxidant therapy, lifestyle modification, and in severe cases, testicular sperm extraction (TESE) combined with ICSI can significantly reduce embryo fragmentation rates.

**For Unexplained RPL or Chromosomal Causes:** IVF with Preimplantation Genetic Testing for Aneuploidies (PGT-A) allows the selection of euploid (chromosomally normal) embryos before transfer, substantially reducing miscarriage risk. IVF success rates in India typically range from 40–55% per cycle depending on age and cause, and PGT-A can shift live-birth rates per transfer considerably higher in RPL populations. HomeIVF offers IVF packages starting from ₹1.5 lakh, making this pathway more accessible to couples across Uttar Pradesh.

**Progesterone Support:** Vaginal micronised progesterone in the luteal phase has shown benefit in a large UK trial (PRISM trial) for women with a history of miscarriage and early pregnancy bleeding. HomeIVF physicians follow updated ESHRE and FOGSI guidance on progesterone supplementation.

HomeIVF was built on a simple but powerful premise: senior-specialist fertility care should not be limited to those who can afford to travel to Delhi or Mumbai. For RPL patients in Lucknow, Varanasi, Kanpur, Agra, Noida, and smaller towns like Meerut or Gorakhpur, this matters deeply.

HomeIVF delivers specialist-level RPL care through a structured model: an initial teleconsultation with a senior reproductive medicine expert (reviewed by the HomeIVF Medical Board), home-based sample collection for the full RPL panel, coordinated ultrasound and uterine imaging at a nearby partner facility, a personalised written management plan, and ongoing monitoring support throughout the next pregnancy attempt.

This is not a replacement for specialist care — it is specialist care, delivered in a format that removes the logistical, financial, and emotional barriers that prevent couples in Uttar Pradesh from accessing it. A woman in Varanasi should receive the same evidence-based RPL workup as one in South Delhi. HomeIVF makes that a reality.

The platform also provides dedicated pregnancy-after-loss monitoring, including early viability scans, hCG trend tracking, and progesterone monitoring during the first trimester — the period of highest anxiety for RPL patients. Coordinators are available in Hindi, ensuring that language is never a barrier to understanding your own care.

Despite being India's most populous state, Uttar Pradesh faces a significant fertility-care gap. The state has a relatively low density of trained reproductive medicine specialists outside of Lucknow and Noida. Couples in Kanpur, Allahabad (Prayagraj), or Agra often face a choice between overburdened government hospitals with limited RPL expertise and private clinics that may not offer the full diagnostic spectrum.

Financial constraints are real. Many families in semi-urban and rural Uttar Pradesh delay seeking RPL care because they assume it will be prohibitively expensive. Fragmented diagnostic services mean couples sometimes pay out-of-pocket for the same test multiple times at different labs.

Cultural stigma also plays a role. Pregnancy loss — particularly repeated loss — is sometimes attributed to the woman's "fault" or to supernatural causes, delaying proper medical consultation. Male factor evaluation is particularly under-sought; many men in Uttar Pradesh are reluctant to undergo sperm testing of any kind.

HomeIVF addresses each of these barriers directly: transparent package pricing removes financial uncertainty, home sample collection eliminates travel burden, Hindi-language teleconsultation normalises help-seeking, and the HomeIVF Medical Board's peer-reviewed care protocols ensure that a couple in rural UP receives the same diagnostic rigour as one in any major Indian metro. The platform actively encourages couple-centric evaluation — meaning both partners are assessed from the first consultation.

The single most common mistake RPL couples make is waiting. Many couples in Uttar Pradesh have their second miscarriage and are told by a local clinician to try once more naturally. While spontaneous successful pregnancy after two losses is possible, each additional loss takes an enormous emotional toll — and may miss a window for intervention that could have prevented it.

The HomeIVF Medical Board recommends seeking a structured RPL consultation after two losses, immediately if any of the following apply: age over 35, a loss after 10 weeks, a known clotting disorder, a history of uterine surgery, or a previous abnormal pelvic scan.

A HomeIVF consultation begins with a detailed intake form covering obstetric history, investigations already done, and current medications. This is followed by a 30–45 minute video consultation with a senior fertility specialist who will review your history, recommend a specific diagnostic panel, and outline a management plan. Within 48–72 hours, a written report is shared with you in clear, accessible language.

For couples in Noida, Ghaziabad, or Greater Noida, in-person coordination with partner clinics can also be arranged for procedures like hysteroscopy or embryo transfer. The entire journey is tracked through the HomeIVF app, with care coordinators available to answer questions between appointments.